The firm touted new assays, provided an update on its nanopore sequencer, and offered insights into upcoming pipeline ...

The initial focus of the partnership will be on trio-based whole genome sequencing for critically ill newborns.

Roche and Broad Clinical Labs collaborate to accelerate adoption of cutting-edge SBX sequencing technology: Basel Saturday, May 24, 2025, 10:00 Hrs [IST] Roche announced a strateg ...

Roche raised the curtain on its novel approach to DNA sequencing earlier this year, and now it's working with the Broad ...

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche's SBX sequencing technology1, with an initial focus on critically ill newborns and their parents.

LHV research points out the following aspects about the EfTEN Real Estate Fund AS: (i) interest costs continue to decrease ...

The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month, Roche said it planned ...

For people with early-stage HER2-positive disease, the APHINITY results validate the sustained benefits of the Perjeta-based regimen,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer ...

In parallel with approving AbbVie's antibody-drug conjugate (ADC), the agency also approved Roche's Ventana MET (SP44) RxDx Assay for identifying patients with c-Met overexpression who are eligible ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...